Qu Biologics Begins Phase 2 Clinical Trial in Ulcerative Colitis
28 juil. 2015 19h33 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 28, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Begins Research Collaboration with Dr. Bruce Vallance at the University of British Columbia to Study SSI Treatment for Inflammatory Bowel Disease
14 juil. 2015 09h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 14, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Appoints Jim Pankovich as Vice President, Clinical Operations and Drug Development
10 juin 2015 09h40 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 10, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted European Patent for Use of Bacterial Compositions for the Treatment of Cancer
11 mai 2015 10h05 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 11, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics to Present at Bloom Burton Healthcare Investor Conference
30 avr. 2015 15h31 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Opens Clinical Trial Sites in Edmonton and Toronto for Crohn's Disease Clinical Trial
24 avr. 2015 15h05 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Crohn's Disease
31 mars 2015 09h40 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Begins Research Collaboration with the University of Rochester, New York
24 mars 2015 10h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Named Life Sciences BC Growth Stage Company of the Year
04 mars 2015 10h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Enrolls First Two Participants in Phase 2a Clinical Trial for Lung Cancer
04 févr. 2015 10h05 HE
|
Qu Biologics;BC Cancer Agency
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...